A Possible Effect of Oxytocin During Interaction Between Humans and Animals
Overview
The purpose of this pilot study is to investigate the possible change of Oxytocin level in human blood after positive interaction with farm animals.
Study Type
- Study Type: Interventional
- Study Design
- Allocation: N/A
- Intervention Model: Single Group Assignment
- Primary Purpose: Basic Science
- Masking: None (Open Label)
- Study Primary Completion Date: November 2011
Detailed Description
The purpose of this pilot study is to investigate the possible change of Oxytocin level in human blood after positive interaction with farm animals and filling in instruments measuring anxiety and stress.
Interventions
- Other: Measuring oxytocin level in blood
- Blood sampling and instruments measuring anxiety and stress
Clinical Trial Outcome Measures
Primary Measures
- Measuring the possible change in Oxytocin level in human blood during intervention with farm animals.
- Time Frame: Start medio October 2010, and end December 2011 (14 months)
- Blood sampling will be drawn at baseline, before intervention starts, and 5 minutes after start. 3rd sample will be drawn 15 minutes after start. Total time of intervention is 15 minutes.
Secondary Measures
- Self evaluation of anxiety and coping strategies.
- Time Frame: Start medio October 2010, and end December 2011 (14 months)
- Spielberger State Anxiety Inventory (SSAI) (Spielberger et al, 1979)and Coping Strategies Scale of the Pressure Management Indicator (Williams & Cooper, 1998.
Participating in This Clinical Trial
Inclusion Criteria
- woman – age 20-30 years old – physical capable of being in a farm environment and have contact with cows Exclusion Criteria:
- pregnancy – breastfeeding – anxiety for blood sampling – anxiety for animals – allergies – psychiatric diagnoses – medication
Gender Eligibility: Female
Minimum Age: 20 Years
Maximum Age: 30 Years
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
Investigator Details
- Lead Sponsor
- Norwegian University of Life Sciences
- Provider of Information About this Clinical Study
- Principal Investigator: Gunn Pedersen, MPh – Norwegian University of Life Sciences
- Overall Official(s)
- Bente Berget, PhD, Principal Investigator, Norwegian University of Life Sciences
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.